Isoflavones from soybeans have an amplifying effect on radiation treatment for lung cancer. In a recent study, radiologists made a concoction out of natural soybean isoflavones, a type of plant estrogen found mainly in soybeans, and injected the lung cancer cells with the concoction before applying  radiation.

It's been established that diet and exercise may delay the impact of Alzheimer's disease on memory, but music? A new study suggests that singing can help with memory loss.

I guess Jack LaLanne had it right. Muscle loss begins in early adulthood. Becoming a 'couch-potato' at 30 will reduce your muscle mass with every bite of pizza.

It is an ironic finding that a nautral sweetener may fight diabetes. New research says not all sweeteners are created equal. 

Chocolate and candy lovers rejoice! New research suggests that moderate intake of sweets is linked to some favorable health measures. You tend to weigh less, have lower body mass indices (BMI), have smaller waist sizes and lower levels of risk factors for cardiovascular disease (CVD) and metabolic syndrome than those who don’t indulge.

Of the 15 percent of U.S. children who suffer from migraines, about one-third of all children, have migraines with aura - which involve a set of symptoms such as flashes of light, blind spots, and tingling. New research shows these migraines in children may be related to a certain heart defect.

Researchers from Johns Hopkins believe that a law banning HIV patients from donating their organs to living HIV-positive patients is outdated. If the ban were reversed, hundreds of HIV-positive patients who need an organ could get their transplant within months instead of years.

The majority of patients with chronic myeloid leukemia recover using various cancer drug treatments. However, they are not cured, as a type of cancerous stem cell is resistant to the drugs.

Juvenile Idiopathic Arthritis (JIA) may involve chronic inflammation of one or more of the patient’s joints.  Most patient see inflammation before the age of 16.  Recent treatment advances have improved lifestyle and long-term results for these patients.

The current two-drug treatment for hepatitis C does not work as well as patients would like. Now, researchers have found that adding a third drug to the mix leads to better results.